Action 4114 SYNMOSA BIOPHARMA CORPORATION
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Synmosa Biopharma Corporation

Actions

4114

TW0004114004

Cours en clôture Taipei Exchange
Autres places de cotation
 00:00:00 07/05/2024 		Varia. 5j. Varia. 1 janv.
39,1 TWD 0,00 % Graphique intraday de Synmosa Biopharma Corporation +1,43 % +1,16 %
29/03 Synmosa Biopharma Corporation présente ses résultats pour l'exercice clos le 31 décembre 2023 CI
16/01 Synmosa Biopharma Corporation annonce des changements dans la cinquième session du comité de rémunération CI

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
Synmosa Biopharma Corporation Reports Earnings Results for the Full Year Ended December 31, 2023
Synmosa Biopharma Corporation Announces Changes in Fifth Session of the Remuneration Committee
Synmosa Biopharma Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Synmosa Biopharma Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Synmosa Biopharma Corporation Announces Cash Dividend, Payable on September 15, 2023
Synmosa Biopharma Corporation Appoints Tu, San-Chien as Additional Independent Director
Synmosa Biopharma Corporation Appoints Tu, San-Chien as Member of the Audit Committee
Synmosa Biopharma Corporation announced that it expects to receive TWD 950 million in funding
Synmosa Biopharma Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023
Synmosa Biopharma Corporation Reports Earnings Results for the Full Year Ended December 31, 2022
Synmosa Biopharma Corporation Approves Dividend for the Year Ended December 31, 2022
Synmosa Biopharma Corporation Announces Changes of Corporate Governance Officer
Synmosa Biopharma Corporation Provides Earnings Guidance for the Year 2022
Synmosa Biopharma Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
Synmosa Biopharma : The Company is invited to attend institutional investor conference held by IBF Securities
Synmosa Biopharma Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
Synmosa Biopharma : To announces SYNMOSA board of directors has lifted the restriction on the prohibition of competition for managerial officer
Synmosa Biopharma : The Company's 2022 Second quarter consolidated financial statements have been reported to the Board
Synmosa Biopharma : Announcement of the Company's adjustment of the number for the transfer treasury shares to employees through the resolution of the board of directors on 7/29
Synmosa Biopharma : Announcement of the Company's board of directors resolution on transfer treasury shares to employees and the record date of share subscription
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action 4114
  4. Actualités Synmosa Biopharma Corporation
  5. Autres langues